Cocrystal Pharma, Inc.
CDI-988
Norovirus
Countdown
87days
Phase 2 readout · Oct 1, 2026
What's at stake
Phase 2 trial results for CDI-988 in Norovirus are due Oct 1, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 13h ago
“CT.gov NCT07198139: Phase 2 trial, sponsor Cocrystal Pharma, Inc., drug CDI-988. Primary completion date 2026-10-01 (estimated).”